Oscar Gary Bukstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Stimulants | 44 | 2020 | 1168 | 2.960 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 56 | 2020 | 3729 | 2.800 |
Why?
|
Methylphenidate | 26 | 2020 | 480 | 2.240 |
Why?
|
Substance-Related Disorders | 40 | 2020 | 4423 | 1.910 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 12 | 2020 | 305 | 1.910 |
Why?
|
Aggression | 13 | 2020 | 750 | 1.100 |
Why?
|
Alcohol-Related Disorders | 10 | 2013 | 243 | 1.040 |
Why?
|
Risperidone | 9 | 2017 | 383 | 0.880 |
Why?
|
Conduct Disorder | 9 | 2014 | 245 | 0.780 |
Why?
|
Alcoholism | 20 | 2018 | 1980 | 0.680 |
Why?
|
Delayed-Action Preparations | 10 | 2020 | 969 | 0.670 |
Why?
|
Psychotropic Drugs | 12 | 2018 | 881 | 0.660 |
Why?
|
Guanfacine | 4 | 2014 | 50 | 0.630 |
Why?
|
Adolescent Behavior | 9 | 2022 | 1186 | 0.620 |
Why?
|
Family Therapy | 3 | 2014 | 214 | 0.580 |
Why?
|
Mass Screening | 3 | 2022 | 5458 | 0.530 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.510 |
Why?
|
Mental Disorders | 18 | 2022 | 6873 | 0.500 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 2 | 2014 | 92 | 0.490 |
Why?
|
Parent-Child Relations | 2 | 2016 | 772 | 0.460 |
Why?
|
Suicide | 3 | 2022 | 1606 | 0.430 |
Why?
|
Adolescent | 84 | 2022 | 89169 | 0.430 |
Why?
|
School Health Services | 2 | 2013 | 388 | 0.390 |
Why?
|
Health Education | 3 | 2014 | 1059 | 0.390 |
Why?
|
Hydrocortisone | 2 | 2011 | 1841 | 0.380 |
Why?
|
Marijuana Abuse | 3 | 2012 | 409 | 0.380 |
Why?
|
Acetylcysteine | 1 | 2012 | 262 | 0.370 |
Why?
|
Child | 69 | 2022 | 80917 | 0.350 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2012 | 451 | 0.340 |
Why?
|
Adrenergic alpha-Agonists | 5 | 2011 | 177 | 0.330 |
Why?
|
Personality | 1 | 2013 | 559 | 0.330 |
Why?
|
Fluoxetine | 8 | 2011 | 733 | 0.320 |
Why?
|
Androstenedione | 1 | 2009 | 132 | 0.320 |
Why?
|
Testosterone | 2 | 2011 | 2491 | 0.320 |
Why?
|
Personality Assessment | 7 | 2008 | 646 | 0.310 |
Why?
|
Parents | 15 | 2017 | 3595 | 0.300 |
Why?
|
Substance Abuse Detection | 2 | 2008 | 301 | 0.290 |
Why?
|
Dehydroepiandrosterone | 1 | 2009 | 259 | 0.290 |
Why?
|
Comorbidity | 27 | 2019 | 10590 | 0.290 |
Why?
|
Saliva | 2 | 2011 | 853 | 0.290 |
Why?
|
Referral and Consultation | 2 | 2020 | 3620 | 0.290 |
Why?
|
Alcohol Drinking | 6 | 2013 | 4045 | 0.280 |
Why?
|
Child Behavior | 1 | 2022 | 864 | 0.260 |
Why?
|
Depressive Disorder, Major | 12 | 2022 | 4818 | 0.260 |
Why?
|
Diagnosis, Dual (Psychiatry) | 8 | 2009 | 300 | 0.250 |
Why?
|
Psychiatric Status Rating Scales | 14 | 2020 | 6029 | 0.250 |
Why?
|
Membrane Lipids | 1 | 2006 | 252 | 0.250 |
Why?
|
Psychiatry | 1 | 2017 | 1716 | 0.240 |
Why?
|
Humans | 131 | 2022 | 768171 | 0.220 |
Why?
|
Depression | 2 | 2022 | 8230 | 0.220 |
Why?
|
Basal Ganglia | 1 | 2006 | 553 | 0.220 |
Why?
|
Double-Blind Method | 21 | 2020 | 12466 | 0.220 |
Why?
|
Clonidine | 3 | 2009 | 170 | 0.220 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2020 | 10763 | 0.210 |
Why?
|
Phospholipids | 1 | 2006 | 787 | 0.210 |
Why?
|
Antipsychotic Agents | 7 | 2017 | 3081 | 0.200 |
Why?
|
Antidepressive Agents | 5 | 2022 | 2913 | 0.200 |
Why?
|
Psychotherapy | 10 | 2022 | 1654 | 0.200 |
Why?
|
Drug Administration Schedule | 8 | 2020 | 4861 | 0.180 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7454 | 0.180 |
Why?
|
Male | 83 | 2020 | 364731 | 0.170 |
Why?
|
Telemedicine | 1 | 2017 | 3109 | 0.170 |
Why?
|
Prefrontal Cortex | 2 | 2008 | 2238 | 0.170 |
Why?
|
Mood Disorders | 4 | 2020 | 1129 | 0.170 |
Why?
|
Dysthymic Disorder | 2 | 2009 | 73 | 0.170 |
Why?
|
Drug Therapy, Combination | 12 | 2017 | 6316 | 0.160 |
Why?
|
Behavior Therapy | 4 | 2010 | 886 | 0.160 |
Why?
|
Female | 79 | 2020 | 397187 | 0.160 |
Why?
|
Antidepressive Agents, Second-Generation | 3 | 2010 | 491 | 0.160 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 8 | 2020 | 1988 | 0.160 |
Why?
|
Temporal Lobe | 1 | 2006 | 1726 | 0.160 |
Why?
|
Bipolar Disorder | 4 | 2014 | 5130 | 0.160 |
Why?
|
Treatment Outcome | 35 | 2022 | 65379 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2009 | 2649 | 0.150 |
Why?
|
Mental Health | 1 | 2022 | 3275 | 0.150 |
Why?
|
Pennsylvania | 9 | 2009 | 615 | 0.140 |
Why?
|
Violence | 2 | 2022 | 936 | 0.140 |
Why?
|
Combined Modality Therapy | 15 | 2017 | 8542 | 0.140 |
Why?
|
Affective Symptoms | 1 | 2020 | 418 | 0.140 |
Why?
|
Interview, Psychological | 5 | 2011 | 810 | 0.140 |
Why?
|
Analysis of Variance | 5 | 2016 | 6229 | 0.140 |
Why?
|
Age of Onset | 4 | 2014 | 3346 | 0.140 |
Why?
|
Phosphorus | 2 | 2008 | 336 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3782 | 0.130 |
Why?
|
Child Psychiatry | 2 | 2009 | 230 | 0.120 |
Why?
|
Dyslexia | 1 | 2017 | 215 | 0.120 |
Why?
|
Anxiety Disorders | 5 | 2020 | 2748 | 0.120 |
Why?
|
Patient Satisfaction | 3 | 2016 | 3490 | 0.120 |
Why?
|
Risk Factors | 14 | 2022 | 74944 | 0.120 |
Why?
|
Achievement | 1 | 2016 | 288 | 0.120 |
Why?
|
Administration, Cutaneous | 4 | 2009 | 716 | 0.120 |
Why?
|
Data Interpretation, Statistical | 1 | 2004 | 2709 | 0.120 |
Why?
|
Peer Group | 4 | 2014 | 700 | 0.110 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.110 |
Why?
|
Forensic Psychiatry | 2 | 2011 | 198 | 0.110 |
Why?
|
Psychometrics | 5 | 2020 | 3063 | 0.110 |
Why?
|
Depressive Disorder | 7 | 2004 | 3721 | 0.110 |
Why?
|
Personality Development | 2 | 1991 | 241 | 0.110 |
Why?
|
Fathers | 1 | 2016 | 377 | 0.110 |
Why?
|
Reading | 1 | 2017 | 543 | 0.110 |
Why?
|
Child Abuse | 2 | 2011 | 1091 | 0.110 |
Why?
|
Socialization | 1 | 1993 | 88 | 0.100 |
Why?
|
Patient Acceptance of Health Care | 2 | 2011 | 3231 | 0.100 |
Why?
|
Cross-Over Studies | 7 | 2020 | 2107 | 0.100 |
Why?
|
Social Perception | 1 | 2016 | 434 | 0.100 |
Why?
|
Internal-External Control | 1 | 2014 | 348 | 0.100 |
Why?
|
Child Custody | 1 | 2011 | 20 | 0.100 |
Why?
|
Child of Impaired Parents | 4 | 1992 | 462 | 0.100 |
Why?
|
Juvenile Delinquency | 1 | 2011 | 116 | 0.090 |
Why?
|
Suicide, Attempted | 3 | 2009 | 1409 | 0.090 |
Why?
|
Child Behavior Disorders | 5 | 2008 | 812 | 0.090 |
Why?
|
Cognition Disorders | 3 | 2012 | 3980 | 0.090 |
Why?
|
Urban Population | 1 | 1998 | 2046 | 0.090 |
Why?
|
Severity of Illness Index | 13 | 2020 | 15949 | 0.090 |
Why?
|
Motivation | 3 | 2011 | 2020 | 0.090 |
Why?
|
Expert Testimony | 1 | 2011 | 266 | 0.090 |
Why?
|
Adolescent Psychiatry | 2 | 2009 | 165 | 0.080 |
Why?
|
Prevalence | 7 | 2009 | 15869 | 0.080 |
Why?
|
Psychology | 2 | 2009 | 353 | 0.080 |
Why?
|
Ganglia | 1 | 2008 | 86 | 0.080 |
Why?
|
Hospitals, Psychiatric | 3 | 2002 | 317 | 0.080 |
Why?
|
Affect | 1 | 2016 | 1495 | 0.080 |
Why?
|
Parenting | 2 | 2014 | 708 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 598 | 0.080 |
Why?
|
Critical Pathways | 2 | 2001 | 476 | 0.070 |
Why?
|
Treatment Refusal | 1 | 2011 | 433 | 0.070 |
Why?
|
Alcohol Deterrents | 2 | 2005 | 49 | 0.070 |
Why?
|
Drug Synergism | 4 | 2016 | 1760 | 0.070 |
Why?
|
Family | 4 | 2009 | 3209 | 0.070 |
Why?
|
Malpractice | 1 | 2011 | 561 | 0.070 |
Why?
|
Social Behavior | 4 | 2015 | 1147 | 0.070 |
Why?
|
Ethics, Medical | 1 | 2011 | 785 | 0.070 |
Why?
|
Sexuality | 1 | 2008 | 179 | 0.070 |
Why?
|
Bupropion | 1 | 2008 | 303 | 0.060 |
Why?
|
Community Mental Health Services | 1 | 2009 | 388 | 0.060 |
Why?
|
Schools | 2 | 2008 | 1498 | 0.060 |
Why?
|
Mothers | 1 | 2016 | 2209 | 0.060 |
Why?
|
Renal Agents | 1 | 2004 | 30 | 0.060 |
Why?
|
Alcohol-Induced Disorders | 1 | 2005 | 27 | 0.060 |
Why?
|
Enuresis | 1 | 2004 | 50 | 0.060 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2004 | 87 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3773 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2009 | 1194 | 0.060 |
Why?
|
Crisis Intervention | 2 | 2002 | 111 | 0.060 |
Why?
|
Medication Adherence | 2 | 2016 | 2187 | 0.050 |
Why?
|
Emergency Services, Psychiatric | 1 | 2003 | 64 | 0.050 |
Why?
|
Adult | 18 | 2017 | 223646 | 0.050 |
Why?
|
Restraint, Physical | 2 | 2002 | 185 | 0.050 |
Why?
|
Neuropsychological Tests | 2 | 2020 | 7140 | 0.050 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 939 | 0.050 |
Why?
|
Personality Inventory | 3 | 2009 | 1018 | 0.050 |
Why?
|
Follow-Up Studies | 12 | 2017 | 39354 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 7073 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1429 | 0.050 |
Why?
|
Substance Abuse Treatment Centers | 3 | 2004 | 155 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3814 | 0.050 |
Why?
|
Sex Factors | 5 | 2008 | 10632 | 0.050 |
Why?
|
Program Development | 1 | 2008 | 1300 | 0.050 |
Why?
|
Young Adult | 5 | 2022 | 60066 | 0.050 |
Why?
|
Patient Isolation | 1 | 2001 | 100 | 0.050 |
Why?
|
Reference Values | 2 | 2005 | 4939 | 0.040 |
Why?
|
Drug Delivery Systems | 2 | 2009 | 2237 | 0.040 |
Why?
|
Placebos | 3 | 2011 | 1667 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 1991 | 2663 | 0.040 |
Why?
|
Residential Treatment | 1 | 2000 | 112 | 0.040 |
Why?
|
Risk-Taking | 1 | 2005 | 1023 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2004 | 1363 | 0.040 |
Why?
|
Cross-Sectional Studies | 8 | 2008 | 26379 | 0.040 |
Why?
|
Evidence-Based Medicine | 3 | 2007 | 3706 | 0.040 |
Why?
|
Demography | 1 | 2004 | 1641 | 0.040 |
Why?
|
Electroconvulsive Therapy | 1 | 2004 | 504 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2593 | 0.040 |
Why?
|
Time Factors | 6 | 2017 | 40220 | 0.040 |
Why?
|
Social Environment | 2 | 2008 | 1012 | 0.040 |
Why?
|
Research | 1 | 2007 | 1979 | 0.040 |
Why?
|
Alcoholic Intoxication | 3 | 2005 | 171 | 0.040 |
Why?
|
Health Personnel | 1 | 2022 | 3384 | 0.040 |
Why?
|
Data Collection | 2 | 2004 | 3326 | 0.040 |
Why?
|
Psychological Techniques | 1 | 2018 | 48 | 0.040 |
Why?
|
Drug Utilization | 1 | 2003 | 1189 | 0.040 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 1999 | 1508 | 0.040 |
Why?
|
Patient Compliance | 3 | 2017 | 2697 | 0.040 |
Why?
|
Synapses | 1 | 2006 | 1764 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2013 | 1587 | 0.030 |
Why?
|
Prognosis | 3 | 2008 | 30009 | 0.030 |
Why?
|
Child, Preschool | 5 | 2022 | 42669 | 0.030 |
Why?
|
Individuality | 2 | 2001 | 307 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 10397 | 0.030 |
Why?
|
Primary Health Care | 1 | 2022 | 4746 | 0.030 |
Why?
|
United States | 10 | 2018 | 73039 | 0.030 |
Why?
|
Wounds and Injuries | 2 | 2005 | 2517 | 0.030 |
Why?
|
Serotonin | 1 | 2020 | 1043 | 0.030 |
Why?
|
Age Factors | 3 | 2008 | 18415 | 0.030 |
Why?
|
Patient Care Management | 1 | 2018 | 303 | 0.030 |
Why?
|
Electrocardiography | 1 | 2008 | 6412 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2010 | 4640 | 0.030 |
Why?
|
Impulsive Behavior | 1 | 2017 | 345 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2352 | 0.030 |
Why?
|
Clonazepam | 1 | 1994 | 135 | 0.030 |
Why?
|
Sleep | 2 | 2008 | 4818 | 0.030 |
Why?
|
Perceptual Distortion | 1 | 1994 | 36 | 0.030 |
Why?
|
Defense Mechanisms | 1 | 1994 | 179 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8052 | 0.030 |
Why?
|
Secondary Prevention | 2 | 2009 | 1474 | 0.030 |
Why?
|
Stereotyped Behavior | 1 | 2013 | 133 | 0.030 |
Why?
|
Behavioral Symptoms | 1 | 2014 | 188 | 0.020 |
Why?
|
Social Adjustment | 2 | 1994 | 635 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1518 | 0.020 |
Why?
|
Patient Dropouts | 1 | 1992 | 411 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2014 | 5315 | 0.020 |
Why?
|
Administration, Oral | 2 | 2010 | 4034 | 0.020 |
Why?
|
Hospitalization | 4 | 1994 | 10840 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2016 | 1007 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 13013 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7951 | 0.020 |
Why?
|
Recreation | 1 | 2009 | 124 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2130 | 0.020 |
Why?
|
Life Change Events | 1 | 1993 | 960 | 0.020 |
Why?
|
Temperament | 1 | 1990 | 301 | 0.020 |
Why?
|
Erythema | 1 | 2009 | 261 | 0.020 |
Why?
|
Observer Variation | 2 | 2007 | 2621 | 0.020 |
Why?
|
Patient Admission | 1 | 1995 | 1365 | 0.020 |
Why?
|
Control Groups | 1 | 2008 | 107 | 0.020 |
Why?
|
Behavior, Addictive | 1 | 1993 | 428 | 0.020 |
Why?
|
Case Management | 1 | 2009 | 277 | 0.020 |
Why?
|
Learning | 1 | 2017 | 1759 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2007 | 22290 | 0.020 |
Why?
|
Confidentiality | 1 | 2011 | 607 | 0.020 |
Why?
|
Neurons | 1 | 2006 | 9514 | 0.020 |
Why?
|
Propylamines | 1 | 2007 | 161 | 0.020 |
Why?
|
Self Concept | 1 | 1993 | 1043 | 0.020 |
Why?
|
Self Efficacy | 1 | 2011 | 643 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 18065 | 0.020 |
Why?
|
Incidence | 3 | 1995 | 21538 | 0.020 |
Why?
|
Firearms | 1 | 1993 | 631 | 0.020 |
Why?
|
Osmosis | 1 | 2006 | 103 | 0.020 |
Why?
|
Bradycardia | 1 | 2008 | 305 | 0.020 |
Why?
|
Anorexia | 1 | 2006 | 153 | 0.020 |
Why?
|
Tachycardia | 1 | 2008 | 599 | 0.020 |
Why?
|
Prodrugs | 1 | 2007 | 274 | 0.020 |
Why?
|
Personality Disorders | 1 | 1990 | 726 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 1993 | 1434 | 0.020 |
Why?
|
Educational Status | 2 | 2008 | 2515 | 0.020 |
Why?
|
Physician's Role | 1 | 2011 | 925 | 0.010 |
Why?
|
Family Health | 1 | 2009 | 1255 | 0.010 |
Why?
|
Education | 1 | 2007 | 533 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1328 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2337 | 0.010 |
Why?
|
Sleep Stages | 1 | 2008 | 706 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2005 | 365 | 0.010 |
Why?
|
Drug Resistance | 1 | 2009 | 1599 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2008 | 643 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 2008 | 472 | 0.010 |
Why?
|
Drug Interactions | 1 | 2008 | 1419 | 0.010 |
Why?
|
Pilot Projects | 2 | 2008 | 8741 | 0.010 |
Why?
|
Brazil | 1 | 2007 | 1250 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2003 | 285 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2004 | 642 | 0.010 |
Why?
|
Pemoline | 1 | 2002 | 18 | 0.010 |
Why?
|
Recurrence | 2 | 2005 | 8509 | 0.010 |
Why?
|
Functional Laterality | 1 | 2008 | 2264 | 0.010 |
Why?
|
Health Status | 1 | 1995 | 4091 | 0.010 |
Why?
|
Regression Analysis | 2 | 2001 | 6340 | 0.010 |
Why?
|
Hospitals, University | 1 | 2003 | 570 | 0.010 |
Why?
|
Amphetamines | 1 | 2002 | 142 | 0.010 |
Why?
|
Prospective Studies | 3 | 2010 | 54924 | 0.010 |
Why?
|
Tics | 1 | 2001 | 76 | 0.010 |
Why?
|
Social Support | 1 | 2011 | 2193 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2007 | 944 | 0.010 |
Why?
|
Psychopharmacology | 1 | 2002 | 146 | 0.010 |
Why?
|
Counseling | 1 | 2008 | 1554 | 0.010 |
Why?
|
Child Day Care Centers | 1 | 2000 | 122 | 0.010 |
Why?
|
Appetite | 1 | 2001 | 247 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5884 | 0.010 |
Why?
|
Patient Advocacy | 1 | 2001 | 362 | 0.010 |
Why?
|
Narcolepsy | 1 | 2002 | 200 | 0.010 |
Why?
|
Program Evaluation | 1 | 2008 | 2507 | 0.010 |
Why?
|
Emergencies | 1 | 2005 | 1221 | 0.010 |
Why?
|
Social Isolation | 1 | 2002 | 366 | 0.010 |
Why?
|
Acute Disease | 1 | 2009 | 7243 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1263 | 0.010 |
Why?
|
Models, Psychological | 1 | 2002 | 825 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2007 | 2029 | 0.010 |
Why?
|
Algorithms | 2 | 2009 | 14164 | 0.010 |
Why?
|
Students | 1 | 2008 | 1744 | 0.010 |
Why?
|
Psychotic Disorders | 2 | 2007 | 3276 | 0.010 |
Why?
|
North America | 1 | 2001 | 1289 | 0.010 |
Why?
|
Quality of Life | 2 | 2009 | 13490 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2004 | 2741 | 0.010 |
Why?
|
History, 20th Century | 1 | 2004 | 2766 | 0.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2006 | 1106 | 0.010 |
Why?
|
Heart Rate | 1 | 2008 | 4214 | 0.010 |
Why?
|
Logistic Models | 2 | 2003 | 13290 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2002 | 964 | 0.010 |
Why?
|
South Australia | 1 | 1995 | 27 | 0.010 |
Why?
|
Brain | 1 | 2002 | 27362 | 0.010 |
Why?
|
Thioridazine | 1 | 1994 | 33 | 0.010 |
Why?
|
Clomipramine | 1 | 1994 | 50 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2721 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1991 | 14783 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9384 | 0.010 |
Why?
|
Utilization Review | 1 | 1995 | 381 | 0.010 |
Why?
|
Diazepam | 1 | 1994 | 214 | 0.010 |
Why?
|
Liver Function Tests | 1 | 1995 | 526 | 0.010 |
Why?
|
Phobic Disorders | 1 | 1995 | 441 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3436 | 0.010 |
Why?
|
Cluster Analysis | 1 | 1997 | 2732 | 0.010 |
Why?
|
Adjustment Disorders | 1 | 1990 | 68 | 0.010 |
Why?
|
Culture | 1 | 1993 | 622 | 0.000 |
Why?
|
Survival Analysis | 1 | 2001 | 10099 | 0.000 |
Why?
|
Odds Ratio | 1 | 1997 | 9669 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1992 | 81760 | 0.000 |
Why?
|
Health Behavior | 1 | 1995 | 2650 | 0.000 |
Why?
|
Borderline Personality Disorder | 1 | 1990 | 767 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2000 | 20225 | 0.000 |
Why?
|
Patient Readmission | 1 | 1995 | 3288 | 0.000 |
Why?
|
Length of Stay | 1 | 1992 | 6498 | 0.000 |
Why?
|
Smoking | 1 | 1995 | 9092 | 0.000 |
Why?
|